Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells.

PubWeight™: 4.51‹?› | Rank: Top 1%

🔗 View Article (PMID 7545266)

Published in N Engl J Med on October 05, 1995

Authors

M Hummel1, K Ziemann, H Lammert, S Pileri, E Sabattini, H Stein

Author Affiliations

1: Institute of Pathology, Klinikum Benjamin Franklin, Freie Universität Berlin, Germany.

Articles citing this

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest (1997) 3.22

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med (1996) 2.75

Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol (1997) 1.39

Hodgkin's disease and the Epstein-Barr virus. Mol Pathol (2000) 1.15

Detection of clonally restricted immunoglobulin heavy chain gene rearrangements in normal and lesional skin: analysis of the B cell component of the skin-associated lymphoid tissue and implications for the molecular diagnosis of cutaneous B cell lymphomas. J Mol Diagn (2000) 0.94

Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues. Proc Natl Acad Sci U S A (1998) 0.93

Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer (2001) 0.85

Clonality of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med (1999) 0.84

Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood (2013) 0.84

A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphoma. Oncotarget (2014) 0.84

Immunoglobulin V genes in Reed-Sternberg cells. N Engl J Med (1996) 0.82

Immunoglobulin V genes in Reed-Sternberg cells. N Engl J Med (1996) 0.80

Pitfalls in diagnostic hematopathology -- Part II. Int J Clin Exp Pathol (2009) 0.80

Immunoglobulin V genes in Reed-Sternberg cells. N Engl J Med (1996) 0.80

Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting. Int J Clin Exp Pathol (2015) 0.78

Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease. Am J Pathol (1996) 0.77

Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol (2011) 0.76

Hodgkin's disease--new insights from immunoglobulin genetics. N Engl J Med (1995) 0.75

Hodgkin's disease: immunoglobulin heavy and light chain gene rearrangements revealed in single Hodgkin/Reed-Sternberg cells. Mol Pathol (1999) 0.75

Articles by these authors

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood (1985) 6.74

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15

Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood (2000) 3.99

Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem (1980) 3.47

Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (1982) 3.26

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell (1992) 3.21

The normal and malignant germinal centre. Clin Haematol (1982) 3.19

A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood (2000) 3.13

Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05

Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood (1989) 2.95

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A (1991) 2.82

Ribonuclease H. An enzyme degrading the RNA moiety of DNA-RNA hybrids. Eur J Biochem (1970) 2.81

Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors". Eur J Immunol (1982) 2.72

Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67

Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology (1998) 2.60

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med (1997) 2.59

Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer (1982) 2.51

WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica (2010) 2.46

Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest (1986) 2.42

Enzyme from calf thymus degrading the RNA moiety of DNA-RNA Hybrids: effect on DNA-dependent RNA polymerase. Science (1969) 2.41

ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41

Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40

ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38

Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol (1992) 2.37

Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol (1985) 2.35

In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology (1989) 2.34

Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet (1985) 2.25

Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet (1984) 2.25

The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Blood (1985) 2.24

Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest (1985) 2.23

Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol (1982) 2.22

Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood (1995) 2.15

Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03

Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res (1984) 2.03

Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol (1997) 2.01

Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol (1990) 2.01

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol (1986) 1.97

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol (1999) 1.95

Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol (1989) 1.89

Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol (1983) 1.85

Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut (1993) 1.83

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81

Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood (2000) 1.79

Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology (1982) 1.78

Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology (1990) 1.77

The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma. J Pathol (2000) 1.76

BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74

Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil. Blood (1996) 1.74

Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer (1982) 1.67

T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology (1999) 1.66

European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL) Ann Oncol (1994) 1.65

Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. Int J Cancer (1985) 1.62

MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol (2009) 1.62

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol (1990) 1.60

Human dendritic reticulum cells of lymphoid follicles: their antigenic profile and their identification as multinucleated giant cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 1.58

Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia (2009) 1.56

Epstein-Barr virus/complement receptor and epithelial cells. Lancet (1989) 1.56

An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel. Histopathology (1984) 1.55

Colonic strictures following nonoperative management of necrotizing enterocolitis. J Pediatr Surg (1975) 1.55

Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol (1991) 1.55

High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol (1990) 1.54

Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol (1996) 1.54

Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) J Pathol (1996) 1.53

Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood (1999) 1.53

Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum Pathol (1989) 1.52

Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep (1982) 1.51

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51

Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood (1992) 1.51

Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51

Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol (1981) 1.50

New approach to assessing lung tumours in man. J Clin Pathol (1986) 1.50

Acquired resistance to Listeria monocytogenes is mediated by Lyt-2+ T cells independently of the influx of monocytes into granulomatous lesions. J Exp Med (1989) 1.50

CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci U S A (1991) 1.47

Evidence for the detection of the normal counterpart of Hodgkin and Sternberg-Reed cells. Hematol Oncol (1984) 1.47

Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood (1992) 1.45

The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol (1990) 1.44

Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol (1993) 1.43

Towards a better definition of human leucocyte surface molecules. Immunol Today (1989) 1.42

Rhabdomyosarcoma presenting as acute leukemia. J Pediatr Hematol Oncol (1996) 1.42

Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia. Cancer (1994) 1.40

Neurological deficit in a consecutive series of vertebral fracture patients with bony fragments within spinal canal. Spinal Cord (1997) 1.38

Risk factors for infection in fracture war wounds (1973 and 1982 wars, Israel) Mil Med (1991) 1.38